Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

American Journal of Psychiatry, Ahead of Print.

Source: American Journal of Psychiatry - April 16, 2018 Category: Psychiatry Authors: Carla M. Canuso Jaskaran B. Singh Maggie Fedgchin Larry Alphs Rosanne Lane Pilar Lim Christine Pinter David Hough Gerard Sanacora Husseini Manji Wayne C. Drevets Source Type: research